CLINICAL TRIALS PROFILE FOR BMS-986278
✉ Email this page to a colleague
Clinical Trials for BMS-986278
Trial ID | Title | Status | Sponsor | Phase | Summary |
---|---|---|---|---|---|
NCT03429933 ↗ | A Study of Experimental Medication BMS-986278 Given to Healthy Participants | Completed | Bristol-Myers Squibb | Phase 1 | The purpose of this study is to investigate experimental medication BMS-986278 given to healthy participants. |
NCT03712540 ↗ | An Investigational Study of Experimental Medication BMS-986278 Given With the Antibiotic Rifampin in Healthy Participants | Completed | Bristol-Myers Squibb | Phase 1 | The purpose of this study is to investigate the effects of experimental medication BMS-986278 given with the antibiotic Rifampin in healthy participants. |
NCT03981094 ↗ | A Study of the Pharmacokinetic Interaction Between Pirfenidone and BMS-986278 in Healthy Participants | Completed | Bristol-Myers Squibb | Phase 1 | The main objectives of this study are to characterize the PK of BMS-986278 after administration of a single dose of BMS-986278 alone or in combination with pirfenidone, as well as to characterize the PK of pirfenidone after administration of a single dose of pirfenidone alone or in combination with BMS-986278 |
NCT04308681 ↗ | A Study Measuring the Effectiveness, Safety, and Tolerability of BMS-986278 in Participants With Lung Fibrosis | Recruiting | Bristol-Myers Squibb | Phase 2 | The purpose of this study is to provide an initial evaluation of the effectiveness of BMS-986278 in participants with lung fibrosis, to demonstrate the safety of BMS-986278, and provide information on the drug levels of BMS-986278 in these participants. |
NCT04468815 ↗ | A Study to Assess the Levels in Blood Plasma of BMS-986278 in Healthy Participants Following Administration of Tablets, With or Without Food, and in the Presence of an Antacid (Esomeprazole) | Not yet recruiting | Bristol-Myers Squibb | Phase 1 | The purpose of this study is to assess levels in blood plasma of BMS-986278 and the food effect in healthy participants. |
NCT04567667 ↗ | Study to Assess the Way the Body Absorbs, Distributes, Breaks Down and Eliminates Radioactive BMS-986278 in Healthy Male Participants | Not yet recruiting | Bristol-Myers Squibb | Phase 1 | The purpose of this study is to assess the way the body absorbs, distributes, breaks down and eliminates radioactive BMS-986278 as well as the safety and tolerability of BMS-986278 in healthy male participants. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Summary |
Clinical Trial Conditions for BMS-986278
Condition Name
Clinical Trial Locations for BMS-986278
Trials by Country
Clinical Trial Progress for BMS-986278
Clinical Trial Phase
Clinical Trial Sponsors for BMS-986278
Sponsor Name